Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to determine the bioequivalency of Synerx Pharma Verapamil extended release capsules.
Epistemonikos ID: a55042fbe5c3ce1dec236faac5dbda9ccbb2cff5
First added on: May 10, 2024